METTL16 Promotes Stability of SYNPO2L mRNA and leading to Cancer Cell Lung Metastasis by Secretion of COL10A1 and attract the Cancer-Associated Fibroblasts
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study identifies SYNPO2L as a key gene in colorectal cancer metastasis, regulated by m6A modification. It promotes cancer spread by influencing cancer-associated fibroblasts and epithelial-mesenchymal transition.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Genomics
Background
- Metastasis significantly worsens colorectal cancer prognosis.
- N6-methyladenosine (m6A) modification is implicated in tumor metastasis.
- Understanding molecular drivers of colorectal cancer metastasis is crucial.
Purpose Of The Study
- To identify m6A-related genes associated with colorectal cancer progression.
- To investigate the role of SYNPO2L in colorectal cancer metastasis.
- To elucidate the regulatory mechanisms of SYNPO2L in cancer progression.
Main Methods
- Analysis of transcriptome data from The Cancer Genome Atlas (TCGA).
- Identification of m6A-related genes using bioinformatics approaches.
- Weighted Gene Co-expression Network Analysis (WGCNA) to explore gene interactions.
- Investigation of protein interactions (Mettl16, YTHDC1, SYNPO2L).
Main Results
- SYNPO2L was identified as a core m6A-regulated gene correlated with poor prognosis and metastasis in colorectal cancer.
- Mettl16 regulates SYNPO2L stability via interaction with YTHDC1.
- SYNPO2L promotes COL10A1 secretion and cancer-associated fibroblast infiltration, driving Epithelial-Mesenchymal Transition (EMT) and metastasis.
Conclusions
- SYNPO2L is a critical mediator of colorectal cancer metastasis.
- The m6A-METTL16-YTHDC1-SYNPO2L axis plays a significant role in cancer progression.
- Targeting SYNPO2L may offer a therapeutic strategy to inhibit colorectal cancer metastasis.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...